2m 2m 2m 2m 2m 2m 2m
TECTONIC THERAP (TECX)
NASDAQ
$37.62-$0.02 (-0.04%)
Price as of Aug 21, 2026 7:30 PM EDT- $735.6MMarket Cap
- 43.74%1-Year Change
- BiotechnologyIndustry
TECTONIC THERAP (TECX)
$37.62-$0.02 (-0.04%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FMR LLC | 15.00% | 2.8M | +13,884 (+0.49%) | Jun 30, 2026 |
TCG CROSSOVER MANAGEMENT, LLC | 6.39% | 1.2M | 0 (0.00%) | Jun 30, 2026 |
ABRDN PLC | 6.05% | 1.1M | 0 (0.00%) | Jun 30, 2026 |
ECOR1 CAPITAL, LLC | 4.96% | 935,121 | 0 (0.00%) | Jun 30, 2025 |
BLACKROCK, INC. | 4.57% | 862,592 | +2,240 (+0.26%) | Jun 30, 2026 |
FIRST LIGHT ASSET MANAGEMENT, LLC | 4.24% | 800,726 | +152,983 (+19.11%) | Jun 30, 2026 |
BAKER BROS. ADVISORS LP | 3.22% | 607,788 | 0 (0.00%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
FIDELITY MT VERNON STREET TRUST | 6.18% | 1.2M | +28,772 (+2.47%) | May 31, 2026 |
TEKLA HEALTHCARE INVESTORS | 4.09% | 770,940 | 0 (0.00%) | Mar 31, 2026 |
iSHARES TRUST | 2.49% | 470,260 | 0 (0.00%) | May 31, 2026 |
VANGUARD INDEX FUNDS | 2.44% | 460,983 | +4,500 (+0.98%) | Mar 31, 2026 |
FIDELITY SELECT PORTFOLIOS | 2.15% | 405,389 | -37,500 (-9.25%) | May 31, 2026 |
TEKLA LIFE SCIENCES INVESTORS | 1.97% | 370,884 | 0 (0.00%) | Mar 31, 2026 |
T. Rowe Price Health Sciences Fund, Inc. | 0.65% | 122,254 | +122,254 (+100.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions86.0M (78.45%)
- Mutual Funds22.5M (20.54%)
- Insiders1.1M (1.01%)
- Other0 (0.00%)
Insider Transactions
- 1.01% (1.1M)Current InsiderOwnership (%, shares)
- 2Number of InsiderBuying (last 12 months)
- $5.5MAmount of InsiderBuying (last 12 months)
- 2Number of InsiderSelling (last 12 months)
- $9.7MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
McNamara Peter Chief Scientific Officer | Exempt | Aug 12, 2026 | $0.00 | 43 | $0.00 | 7,830 |
McNamara Peter Chief Scientific Officer | Exempt | Aug 12, 2026 | $632.53 | 43 | $14.71 | 55,328 |
McNamara Peter Chief Scientific Officer | Sell | Aug 12, 2026 | $1,505.00 | 43 | $35.00 | 55,285 |
Lochner Daniel Chief Financial Officer | Award | Jun 11, 2026 | $0.00 | 7,500 | $0.00 | 7,500 |
Vitorovic Stefan | Award | Jun 09, 2026 | $0.00 | 10,200 | $0.00 | 10,200 |
Chutter Jessica Caroline | Award | Jun 08, 2026 | $0.00 | 20,400 | $0.00 | 20,400 |
Nader Francois | Award | Apr 01, 2026 | $0.00 | 20,400 | $0.00 | 20,400 |
Ruddy Marcella K. Chief Medical Officer | Sell | Apr 01, 2026 | $31,050.00 | 1,000 | $31.05 | 68,747 |
McNamara Peter Chief Scientific Officer | Exempt | Mar 06, 2026 | $0.00 | 2,500 | $0.00 | 31,959 |
McNamara Peter Chief Scientific Officer | Exempt | Mar 06, 2026 | $0.00 | 215 | $0.00 | 8,045 |
McNamara Peter Chief Scientific Officer | Exempt | Mar 06, 2026 | $5,950.00 | 2,500 | $2.38 | 61,332 |
McNamara Peter Chief Scientific Officer | Exempt | Mar 06, 2026 | $3,162.65 | 215 | $14.71 | 61,547 |
McNamara Peter Chief Scientific Officer | Sell | Mar 06, 2026 | $181,410.00 | 6,047 | $30.00 | 55,500 |
McNamara Peter Chief Scientific Officer | Sell | Mar 06, 2026 | $7,525.00 | 215 | $35.00 | 55,285 |
Lochner Daniel Chief Financial Officer | Award | Mar 04, 2026 | $0.00 | 24,250 | $0.00 | 24,250 |
McNamara Peter Chief Scientific Officer | Award | Mar 04, 2026 | $0.00 | 21,000 | $0.00 | 21,000 |
Ruddy Marcella K. Chief Medical Officer | Award | Mar 04, 2026 | $0.00 | 24,250 | $0.00 | 24,250 |
McNamara Peter Chief Scientific Officer | Award | Mar 04, 2026 | $0.00 | 23,000 | $0.00 | 60,482 |
Lochner Daniel Chief Financial Officer | Award | Mar 04, 2026 | $0.00 | 26,500 | $0.00 | 58,544 |
McNamara Peter Chief Scientific Officer | Sell | Mar 04, 2026 | $41,250.00 | 1,650 | $25.00 | 58,832 |
REICIN ALISE Chief Executive Officer | Award | Mar 04, 2026 | $0.00 | 69,250 | $0.00 | 69,250 |
Ruddy Marcella K. Chief Medical Officer | Award | Mar 04, 2026 | $0.00 | 26,500 | $0.00 | 79,747 |
REICIN ALISE Chief Executive Officer | Award | Mar 04, 2026 | $0.00 | 76,500 | $0.00 | 311,547 |
McNamara Peter Chief Scientific Officer | Sell | Mar 03, 2026 | $36,376.94 | 1,649 | $22.06 | 37,482 |
REICIN ALISE Chief Executive Officer | Buy | Feb 11, 2026 | $52,750.00 | 2,500 | $21.10 | 237,547 |
Schwabish Marc Chief Business Officer | Exempt | Feb 10, 2026 | $0.00 | 4,500 | $0.00 | 82,014 |
Lochner Daniel Chief Financial Officer | Buy | Feb 10, 2026 | $129,660.00 | 6,000 | $21.61 | 32,044 |
Schwabish Marc Chief Business Officer | Exempt | Feb 10, 2026 | $10,710.00 | 4,500 | $2.38 | 25,814 |
REICIN ALISE Chief Executive Officer | In Kind | Feb 04, 2026 | $95,294.88 | 4,104 | $23.22 | 235,047 |
Schwabish Marc Chief Business Officer | In Kind | Feb 04, 2026 | $37,593.18 | 1,619 | $23.22 | 21,314 |